Literature DB >> 25203733

Social inference in individuals at clinical high risk for psychosis.

Kelly E Gill1,2, Victoria Cressman3, Sarah Lucy Poe1,2, Sara Steinfeld1, Shelly Ben-David1,4, John G Keilp1, Holly Moore1,2, Lyn S Turkstra5, Cheryl Corcoran1,2.   

Abstract

AIM: Social cognition impairment is a hallmark of schizophrenia and contains multiple domains. The domain of social inference has been relatively understudied in schizophrenia and its risk states.
METHODS: Social inference was assessed in 60 clinical high-risk (CHR) patients and 28 healthy control subjects, using the video social inference task. We hypothesized a deficit in social inference in CHR participants and examined predictive value for psychosis transition.
RESULTS: Social inference was positively associated with increasing age. Social inference did not differ significantly between CHR patients and controls, or predict transition to psychosis.
CONCLUSIONS: Few studies have examined social inference of individuals at clinical high risk for psychosis, and findings have been inconclusive. Additional studies using a variety of measures of social inference in CHR participants are recommended.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical high risk; psychosis; social cognition; social inference

Mesh:

Year:  2014        PMID: 25203733     DOI: 10.1111/eip.12182

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  2 in total

1.  Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis.

Authors:  R J M van Donkersgoed; L Wunderink; R Nieboer; A Aleman; G H M Pijnenborg
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

2.  The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review.

Authors:  Louise Birkedal Glenthøj; Carsten Hjorthøj; Tina Dam Kristensen; Charlie Andrew Davidson; Merete Nordentoft
Journal:  NPJ Schizophr       Date:  2017-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.